Login to Your Account

FDA processes feed concerns regarding combo policy group

By Mark McCarty
Regulatory Editor

Friday, May 12, 2017

The formation of the FDA Combination Product Policy Council (CPPC) may be a harbinger of good things to come for combination product reviews, but comments from industry suggest that the agency's processes – including those for resolving disputes between the FDA's centers – continue to feed industry's doubts.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription